Deconstructing Actavis v Eli Lilly

The Supreme Court's decision in Actavis v Eli Lilly [2017] UKSC 48 has changed the way that the UK courts will determine the extent of protection of a patent's claim. Prior to this decision, since the House of Lords' decision in Catnic Components v Hill [1982] RPC 183 the UK courts has used "purposive construction" in order to establish the scope of a patent's claim.

As famously explained by Lord Hoffmann in the seminal decision of the House of Lords in Kirin Amgen v Hoechst Marion Roussel [2005] RPC 9 the crux of purposive construction is to determine "what the person skilled…

Full article available on PatentHub

Latest insights

More Insights
featured image

Be quick to file an application for a cost decision at the UPC - or it could be a costly mistake

6 minutes Aug 21 2025

Read More
featured image

Reshaping the Game: An EU-Focused Legal Guide to Generative and Agentic AI in Gaming

Aug 14 2025

Read More
Curiosity line blue background

Hong Kong’s Clinics to Prepare for Licensing Regime

Aug 13 2025

Read More